Furman B L, Wilson G A
Eur J Pharmacol. 1979 May 1;55(3):241-6. doi: 10.1016/0014-2999(79)90190-0.
The effects of levodopa on plasma glucose were examined in two strains of rats. In fasted Wistar rats levodopa produced a dose-dependent hyperglycaemic response which was augmented by pretreatment with nialamide. This response in nialamide-treated rats was prevented by pretreatment with phentolamine and converted to a hypoglycaemic response. Phentolamine increased the plasma concentration of immunoreactive insulin (IRI). In phentolamine-pretreated rats levodopa produced a further marked increase in the plasma IRI concentration. It is suggested that the prevention of levodopa hyperglycaemia by phentolamine is due to the marked increase in the plasma IRI concentration produced by pretreatment with phentolamine. Moreover the fall in the plasma glucose concentration produced by levodopa in phentolamine-pretreated rats is likely to be due, at least in part, to the additional increase in the plasma IRI concentration produced by levodopa under these conditions. In contrast, in fasted Sprague-Dawley rats pretreated with nialamide, levodopa produced either no effect on plasma glucose, or in larger doses, a marked hypoglycaemic effect followed by death. This hypoglycaemic effect was accompanied by a decrease in the plasma IRI concentration.
在两种品系的大鼠中研究了左旋多巴对血糖的影响。在禁食的Wistar大鼠中,左旋多巴产生剂量依赖性的高血糖反应,用尼亚酰胺预处理可增强该反应。在用酚妥拉明预处理后,尼亚酰胺处理的大鼠中的这种反应被阻止,并转变为低血糖反应。酚妥拉明增加了免疫反应性胰岛素(IRI)的血浆浓度。在酚妥拉明预处理的大鼠中,左旋多巴使血浆IRI浓度进一步显著增加。提示酚妥拉明对左旋多巴高血糖的预防作用是由于酚妥拉明预处理使血浆IRI浓度显著增加。此外,左旋多巴在酚妥拉明预处理的大鼠中导致的血浆葡萄糖浓度下降,至少部分可能是由于在这些条件下左旋多巴使血浆IRI浓度进一步增加所致。相比之下,在禁食的经尼亚酰胺预处理的Sprague-Dawley大鼠中,左旋多巴对血糖要么没有影响,要么在大剂量时产生显著的低血糖作用并导致死亡。这种低血糖作用伴随着血浆IRI浓度的降低。